Literature DB >> 5074556

The platelet aggregating effect of eight commercial heparins.

C Eika.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5074556     DOI: 10.1111/j.1600-0609.1972.tb00973.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


× No keyword cloud information.
  8 in total

1.  The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defects.

Authors:  A Girolami; L De Marco; L Virgolini; R Peruffo; F Fabris
Journal:  Blut       Date:  1975-10

Review 2.  Platelets, thrombosis and drugs.

Authors:  J F Mustard; M A Packham
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 3.  Effect of heparin and heparin fractions on platelet aggregation.

Authors:  E W Salzman; R D Rosenberg; M H Smith; J N Lindon; L Favreau
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

Review 4.  Pharmacokinetic, pharmacodynamic and pharmacogenetic profile of the oral antiplatelet agent ticagrelor.

Authors:  Renli Teng
Journal:  Clin Pharmacokinet       Date:  2012-05-01       Impact factor: 6.447

5.  Increased sensitivity of arachidonic acid-induced platelet aggregation in the presence of carbon dioxide.

Authors:  P J Kerry; C J Paton
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

6.  Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.

Authors:  G P Visentin; S E Ford; J P Scott; R H Aster
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

7.  [Influence of five commercial heparin preparations on the collagen induced platelet aggregation (author's transl)].

Authors:  G Kronik; E Deutsch
Journal:  Blut       Date:  1977-11-22

8.  Thrombotic complications of heparin therapy: including six cases of heparin--induced skin necrosis.

Authors:  P W White; J R Sadd; R E Nensel
Journal:  Ann Surg       Date:  1979-11       Impact factor: 12.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.